| INTRODUCTION
Perioperative goal-directed therapy refers to the haemodynamic optimisation during perioperative care by titrating fluids, vasopressors, and/or inotropes to predefined haemodynamic goals. 1 The main purpose of perioperative goal-directed therapy is to maintain or restore sufficient oxygen delivery by providing adequate organ and tissue perfusion. However, both under-resuscitation with insufficient organ perfusion and over-resuscitation may lead to adverse outcomes. 2 In 1988, Shoemaker was the first to report lower mortality and morbidity rates associated with perioperative goal-directed therapy Thomas Kaufmann and Ramon P. Clement are joint first authors.
compared with standard care, followed by a plethora of other trials. 3 Shoemaker used invasive pulmonary artery catheter (PAC) monitoring to guide his interventions. In the past, such catheters were the most widely used technique although a clear survival benefit was never proven. 4 More recently, less-invasive and even non-invasive monitoring devices are used to reduce the risks associated with more invasive techniques. The British National Institute for Health and Care Excellence (NICE) and a report commissioned by the Centers for Medicare and Medicaid Services in the USA recommended the use of oesophageal Doppler monitoring (ODM) for optimising haemodynamics in patients undergoing major surgery. 5, 6 While most literature on perioperative goal-directed therapy evaluated patients having major gastrointestinal surgery, the data expand to orthopaedic, cardiothoracic and vascular surgery. [7] [8] [9] Several meta-analyses have been published on the use of perioperative goal-directed therapy in various types of patients, but conclusions are inconsistent. [10] [11] [12] [13] Furthermore, perioperative goal-directed therapy is not widely implemented in clinical practice across Europe. 14 Recently, reviews evaluated specific types of surgery or haemodynamic monitoring devices. 13, 15 To provide a more extensive overview of perioperative goal-directed therapy, the aim of this systematic review was to investigate the benefits and harms of perioperative goal-directed therapy in patients having all types of surgery regardless of the protocol used.
| ME TH ODS
This systematic review was conducted following our protocol registered on the PROSPERO database (CRD42016035548) following the recommendations of The Cochrane Handbook for Systematic
Reviews of Interventions and Grading of Recommendations Assessment, Development and Evaluation (GRADE). 16, 17 We reported this review according to the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) statement (Table S1 ). 18 
| Eligibility criteria
All trials published in English, irrespective of blinding, publication status or sample size were considered for assessment of benefits and harms. Quasi-randomised trials where the method of allocating participants to a treatment was not strictly random and observational trials were excluded. All trials evaluating any type of perioperative goal-directed therapy were considered for inclusion, irrespective the type of surgery, the goal-directed therapy algorithm, the types of vasopressors and inotropes used, the haemodynamic variable and its value targeted. All trials were included irrespective of the control intervention.
Perioperative goal-directed therapy was defined by any haemodynamic monitoring along with interventions aimed at optimising haemodynamics during the perioperative period to achieve a specified predetermined haemodynamic target value. Trials had to describe the interventions, including the haemodynamic monitoring device, the haemodynamic variable and target value and the types and amounts of fluids and/or inotropes used. Such a clear description was required for the intervention group, but not for the control group.
The primary outcome was all-cause mortality (at longest followup). The first secondary outcome was serious adverse events (SAE)
excluding mortality (to avoid double counts). SAE is a composite outcome summarising all serious events necessitating an intervention and/or operation and/or prolonged hospital stay excluding mortality according to ICH-GCP definitions. 19 Other secondary outcomes were hospital and ICU length of stay. Finally, we also considered the surrogate outcome of the total amounts of fluids administered.
| Search strategy
We searched The Cochrane Central Register of Controlled Trials (CENTRAL) of The Cochrane Library, PubMed/MEDLINE, Web of Science and EMBASE. Furthermore, references of identified trials and (systematic) reviews were cross-searched. In addition, Google Scholar (Google Inc.) was used for 'cited reference search' by backwards snowballing (Supplement S1). We used no time restrictions.
The final search was performed on 2 May 2018.
| Study selection and data extraction
Two authors (TK, RPC) independently selected trials for inclusion.
Excluded trials based on full text are listed with reasons for exclusion ( Figure 1 ). Two authors independently performed data extraction, including trial characteristics (lead author, publication year, numbers of patients enrolled), participant characteristics (baseline characteristics, inclusion and exclusion criteria and types of surgery), intervention characteristics (haemodynamic variable and its value targeted, monitoring devices, interventions used) and all outcomes.
| Bias risk assessment
The risks of bias were assessed by two authors (TK, RPC), independently, without masking of trial names following The Cochrane
Handbook for Systematic Reviews of Interventions. 16 Any differences in opinion were resolved through discussion. The following
Editorial Comment
In this trustworthy systematic review, the authors critically assessed perioperative goal-directed therapy trials and found that they were severely heterogeneous with regard to the populations, interventions and outcomes of interest. Statistical heterogeneity was explored by the chi-squared test with significance set at P-value of 0.10, and the quantity of heterogeneity was measured by I-squared. 22 We planned on performing the following subgroup analyses: (a) trials with overall low risk of bias compared to trials with overall high risk of bias; (b) the intervention effect in the trials depending on the type of surgery. Only subgroup analyses showing statistical significant test of interactions (P < 0.05) were considered to provide evidence of an intervention effect pending the subgroup.
A funnel plot was used to explore small trial bias and to use asymmetry in funnel plot of trial size against treatment effect to assess this bias if data on more than 10 trials were available. 16 
| GRADE
We used the GRADE system to assess the quality of the body of evidence associated with each of the major outcomes in our review using GRADE software. 17 The quality measure of a body of evidence considers within-trial risk of bias, indirectness, heterogeneity, imprecision and risk of publication bias.
| RESULTS
Our search strategy identified 2852 unique citations. After removal of duplicates, 1836 remaining hits were screened based on title and abstract. In all, 258 full-text articles were assessed for eligibility.
After exclusion of 146 hits, 112 trials were selected for inclusion in this systematic review, of which 15 trials were identified through cross-reference searching (snowballing; Figure 1 ).
F I G U R E 1 Flowchart of study selection

| Characteristics of the included trials
In total, 112 trials with 13 562 patients were included in this systematic review. 3, 4, [7] [8] [9] The characteristics of the 112 included trials are listed in the supplements (Table S2A-E) . Nine trials used a three-arm parallel group design; all other trials used a two-arm parallel group design.
| Risk of bias
Adequate sequence generation was used in 82 trials (73%), allocation concealment was used in 58 trials (52%), blinding of participants and personnel was used in 23 trials (21%) and blinding of outcome assessors was used in 61 trials (64%). Complete outcome data were reported in 88 trials (79%). There was a low risk of bias regarding selective outcome reporting in 103 trials (92%), and 72 trials (64%)
had no other risks of bias. One trial (1%) had a low overall risk of bias and 111 trials (99%) had high overall risk of bias ( Figure 2 and Figure S1 ).
| Characteristics of the patients included in the trials
The types of surgery that the patients in the trials underwent included abdominal surgery (43 trials; 38%), cardiothoracic surgery (16 trials; 14%), high-risk surgery (13 trials; 12%), orthopaedic surgery (eight trials; 7%), vascular surgery (nine trials; 8%), liver surgery (six trials; 5%), plastic surgery (five trials; 4%), neurosurgery (three trials; 3%), trauma surgery (three trials; 3%), thoracic surgery (two trials; 2%) and other surgery or left unspecified in five trials (4%).
| Timing of the intervention
The timing of the conduct of the perioperative goal-directed therapy intervention varied between trials. The majority of 70 trials (63%) only intervened during surgery, one trial (1%) only intervened before surgery, 11 trials (10%) performed the intervention exclusively postsurgery and 30 trials (27%) used extended durations.
| Haemodynamic target variable
We identified a total of 30 different variables used as targets in the trials to guide the interventions. These consisted of static variables such as heart rate (HR), mean arterial pressure (MAP), cardiac output (CO), 
| Monitoring devices
In total, 18 different haemodynamic monitoring devices were used in the trials (Table S2B) 
| Fluids
All trials used some combination of fluids and vasoactive medications to achieve the targeted haemodynamic value. Regarding fluid interventions, 61 trials (54%) used only colloids, 10 trials (9%) used only (two trials; 2%), milrinone (two trials; 2%), cafedrine (one trial; 1%), theodrenaline (one trial; 1%) and vasopressin (one trial; 1%). In 28 trials (25%), the types of vasopressors and/or inotropes used were either unspecified or were left at the discretion of the anaesthesiologist.
| Vasopressors and/or inotropes
| Outcomes
We observed vast clinical heterogeneity included in the trials for type of surgery but also in all individual components of the complex intervention of perioperative goal-directed therapy, including the timing of the intervention, the type of monitoring device, the haemodynamic variables assessed, the haemodynamic value targeted, the types and amounts of fluids given, the types of vasopressors and/or inotropes used (Table 1) . Due to such observed clinical heterogeneity, it was deemed inappropriate to pool any of the data into a pooled intervention effect estimate, and therefore, no metaanalysis was conducted following recommendations of The Cochrane
Handbook for Systematic Reviews of Interventions. 
| Primary outcome
Eighty-seven trials (78%) reported mortality, the timing of which varied from perioperative mortality up to 1 year mortality or was left unspecified. Furthermore, causation of mortality in this outcome varied from all-cause to specific causes such as cardiac death. Mortality varied from 0% to 34% in the intervention groups and from 0% to 44% in the control groups (Figure 3) . Statistical heterogeneity CFT, corrected velocity time; CI, cardiac index; CVL, central venous line; CVP, central venous pressure; DO2, delivery of oxygen; GEDVI, global end diastolic volume index; intra, intraoperative; ITBVI, intra thoracic blood volume index; MAP, mean arterial pressure; N/S, not specified; O2ER, oxygen extraction ratio; ODM, oesophageal Doppler monitor; PAC, pulmonary artery catheter; PAOP, pulmonary artery occlusion pressure; post, postoperative; PPV, pulse pressure variation; pre, preoperative; PVI, pleth variability index; RVEDVI, right ventricular end diastolic volume index; ScvO2, central venous oxygen saturation; SV, stroke volume; SVI, stroke volume index; SVV, stroke volume variation; VCCI, vena cava collapsibility index.
F I G U R E 3
Forest plot of all-cause mortality at maximum follow-up. Subgroups were constructed and classified according to high or low risk of bias. Due to clinical heterogeneity, meta-analysis was deemed inappropriate [Colour figure can be viewed at wileyonlinelibrary.com] measured by I 2 was 12%. A funnel plot suggested no arguments for bias ( Figure 4) . We also evaluated subgroups classified according to type of surgery ( Figure 5 ). We did not perform meta-analysis in these subgroups as there still was significant clinical heterogeneity based on all other variables.
| Secondary outcomes
The SAEs that were reported varied from one single-specific complication, such as postoperative ileus or kidney failure, to multiple predefined adverse outcomes in several organ systems (Table S2C) . None of the trials reported SAE according to the ICH-GCP definitions.
Hospital stay was reported in 78 trials (70%) and ICU stay was reported in 40 trials (36%). Hospital stay varied from 2 to 31 days and length of ICU stay varied from 0 to 15 days (Table S2E ).
The types of fluids given in the intervention and control groups varied substantially (Table S2B ). Details on total amounts of fluids given were reported in 104 trials (93%). The amounts of fluids given were either reported as total amounts given during the trial or as total amounts of each type of fluid or as mL/kg/h. Total amounts of fluids given ranged from no additional fluid to nearly 22 L of crystalloids in severe trauma patients (Table S2E ).
| GRADE
The quality of the evidence was assessed as very low for all outcomes based on risk of bias limitations, indirectness, inconsistency, imprecision and other considerations ( Table 2 ).
| DISCUSSION
We conducted a systematic review of perioperative goal-directed therapy and found 112 randomised trials. Only one trial (1%) had a low overall risk of bias. Perioperative goal-directed therapy was tested in patient groups of at least 10 different types of surgery.
There was very large clinical heterogeneity, not only in the types of patients but even more in the complex intervention of perioperative goal-directed therapy including its component interventions and also Many meta-analyses have been conducted for evaluation of perioperative goal-directed therapy for specific patient categories. [10] [11] [12] [13] Others narrowed their research question to specific perioperative goal-directed therapy interventions, limiting clinical heterogeneity in the interventions used. For example, one systematic review only evaluated LidCO-based fluid management during hip surgery. 83 Such narrowing has advantages in terms of population and device definitions at the costs of reduced power and reduced generalisability of the perioperative goal-directed therapy intervention. However, even within one trial or within a focused systematic review, patients may differ in several aspects. We chose to include trials irrespective of type of surgery because national guidelines recommend the use of perioperative goal-directed therapy in major surgery. 5, 6 Experts recognise that evaluation of the perioperative goaldirected therapy intervention is impeded by large clinical heterogeneity, especially considering the changes over time. 130, 131 Earlier perioperative goal-directed therapy trials targeted supranormal haemodynamic values compared to a more restrictive fluid regimen applied in more recent trials. Researchers have adopted lessons learnt from earlier trials into new trials so that the perioperative goal-directed therapy intervention might have evolved. 132 Furthermore, general advancements in medicine might have reduced mortality both in the intervention group and in the control group over time. Therefore, merging data from earlier trials with data from more recent trials into one pooled intervention effect estimate may be inappropriate.
During this systematic review, we made several deviations from our published protocol. First, there were no data on the composite outcome SAEs, and we were therefore unable to report this. We recognise the difficulty associated with the definition and registration of SAEs and did not take into account that most of the included trials were published before SAE definitions by ICH-GCP were developed.
Third, we also included trials if most of the perioperative goal-directed therapy protocol was described. Last, since the total amount of administered fluids and length of hospital stay were reported inconsistently, we could not perform statistical analyses on both outcomes.
We aimed to present the extracted data for this systematic review as accessible as possible. However, we realise that, without meta-analyses, we ask the reader to analyse the data on their own using the supplementary table in order to fully appreciate this work (Table S2 ).
In general, randomised trials with low overall risk of bias are needed before the conclusion can be drawn that any intervention is beneficial. 133 The beneficial effects of perioperative goal-directed therapy need confirmation by trials with low overall risks of bias. While mortality is not a surrogate outcome, we deemed it necessary to classify as very serious due to the significant differences in PGDT algorithms and patient categories.
e Most trials were inadequately powered to detect a difference in the outcome mortality considering the very low event rate. f Funnel plots showed no clear asymmetry. 
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